MedTrace Logo

Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx

NCT02552550 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2018-06-04

No results posted yet for this study

Summary

The curative treatment and organ preservation in advanced squamous cell carcinoma of the oropharynx is multimodal. It involves induction chemotherapy and depending on the response radio-chemotherapy or surgery. The combination of these methods has important functional consequences.

The aim of this prospective pilot study is to describe swallowing, speech, but also patients' quality of life before and after therapeutic management (existing studies measuring these functions after treatment but not before).

Conditions

  • Squamous Cell Carcinoma of the Oropharynx

Interventions

PROCEDURE

Ability to swallow, speak and quality of life

This study will not change the patient's treatment. This will just be an evaluation, before any treatment, his ability to swallow, speak, then his quality of life, as in normal practice, after 3, 6 and 12 months after treatment.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Jean-Michel PRADES, MD PhD · CHU de SAINT-ETIENNE

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-25
Primary Completion
2016-09-20
Completion
2016-09-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02552550 on ClinicalTrials.gov